Aksh Optifibre Ltd (AKSHOPTFBR) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Aksh Optifibre Ltd on NSE and BSE, with an AI summary of each filing.
Voting Results & Scrutinizer''s Report
Annual General Meeting · 29 Sept 2026, 1:43 am
Aksh Optifibre 39th AGM Voting Results and Scrutinizer Report Aksh Optifibre announced the voting results of its 39th AGM held on 28th Sep'26, where shareholders approved all four ordinary resolutions with over 99.9% majority. Key approvals included the adoption of FY26 standalone and consolidated audited financial statements, the reappointment of Dr. Kailash Shantilal Choudhari as Director, the reappointment of Satyendra Kumar Gupta as Professional Consultant, and the ratification of Cost Auditor remuneration for FY27. Total votes polled represented 23.71% of outstanding shares. The company continues operations under Interim Resolution Professional supervision per NCLAT directives.
Proceedings of 39th Annual General Meeting
Annual General Meeting · 29 Sept 2026, 1:39 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs. Mona Kailash Choudhari & PAC
Acquisition/ Disposal of Shares · 26 Sept 2026, 4:37 pm
Promoter Group Member Trims Stake in Aksh Optifibre Mrs. Mona Kailash Choudhari, belonging to the promoter group of Aksh Optifibre Limited, sold 1,34,165 equity shares (0.09% stake) via an open-market transaction on 24th Sep'26. Following the disposal, her direct holding decreased from 26,94,129 shares (1.66%) to 25,59,964 shares (1.57%). Additionally, Person Acting in Concert (PAC) Dr. Kailash Shantilal Choudhari holds 42,52,245 shares, representing a 2.61% stake in the company. Total voting capital remains unchanged at 16,26,97,971 equity shares.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mona Kailash Choudhari
Acquisition/ Disposal of Shares · 25 Sept 2026, 4:58 pm
Aksh Optifibre Promoter Group Offloads Stake via Open Market Promoter group entity Dr. Kailash Shantilal Choudhari sold 93,157 equity shares (0.05% stake) of Aksh Optifibre Limited via open market transactions between 22nd Sep'26 and 23rd Sep'26. Consequently, Dr. Choudhari's direct shareholding decreased from 27,87,286 shares (1.71%) to 26,94,129 shares (1.66%). The disclosure was formally submitted under Regulation 29(2) of SEBI SAST Regulations by Mrs. Mona Kailash Choudhari on 24th Sep'26, reflecting the overall promoter group holding adjustments against the company's total paid-up equity base of 16,26,97,971 shares.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mona Kailash Choudhari & PACs
Acquisition/ Disposal of Shares · 23 Sept 2026, 4:33 pm
Aksh Optifibre Promoter Group Sells 0.09% Stake via Open Market Promoter group entity Dr. Kailash Shantilal Choudhari sold 1,43,436 equity shares (representing a 0.09% stake) of Aksh Optifibre Limited via open market transactions on 21st Sep'26. Following the disposal, Dr. Choudhari's direct shareholding in the company decreased from 29,30,722 shares (1.80%) to 27,87,286 shares (1.71%). The total equity share capital of the target company remains unchanged at 16,26,97,971 equity shares valued at Rs. 81,34,89,855. Mrs. Mona Kailash Choudhari disclosed the transaction under SEBI SAST Regulations on 22nd Sep'26.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mona Kailash Choudhari & PACs
Acquisition/ Disposal of Shares · 22 Sept 2026, 4:54 pm
Aksh Optifibre Promoter Group Sells Stake via Open Market Promoter group member Mona Kailash Choudhari disclosed the open-market sale of 69,278 equity shares (0.04% stake) in Aksh Optifibre Limited by Dr. Kailash Shantilal Choudhari on 18th Sep'26. Following this disposal, Dr. Kailash Shantilal Choudhari's direct holding decreased from 30,00,000 shares (1.84%) to 29,30,722 shares (1.80% of total voting capital). The total PAC holding stands at 42,52,245 shares or 2.61% of the company's total equity base of 16,26,97,971 shares (Rs. 81.35 cr paid-up capital).
Notice of 39th Annual General Meeting (AGM) for the financial year 2025-26
Annual General Meeting · 01 Sept 2026, 11:52 pm
Notice & Annual Report for the Financial Year ended 2025-26
Others (Uncategorized) · 01 Sept 2026, 11:49 pm
Financial Results for the Quarter ended June 30, 2026
Financial Result · 15 Aug 2026, 2:50 am
Aksh Optifibre: Q1FY27 Results Show Profitability Turnaround Amidst Insolvency Process Aksh Optifibre reported a significant turnaround in Q1 FY27 (ended 30 Jun'26), posting a standalone Profit After Tax (PAT) of ₹5.38 cr versus a loss of ₹3.76 cr YoY. Revenue from operations grew 85.6% YoY to ₹49.87 cr. The company is currently under a Corporate Insolvency Resolution Process (CIRP) initiated on 19 Jun'26. Auditors issued a qualified conclusion, noting unrecognized liabilities of ₹30.43 cr and an impairment loss of ₹0.55 cr, which would have overstated Q1 PAT by a combined ₹0.97 cr.
Outcome of Board Meeting for approval of Unaudited Financial Results for the Quarter ended June 30, 2026
Outcome · 15 Aug 2026, 2:43 am
Aksh Optifibre Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 4,987 (+85.4% YoY | +22.1% QoQ) ■ EBITDA: 1,031 (Loss to Profit YoY | +544.7% QoQ) ■ EBITDA Margin (%): 20.7 (Loss to Profit YoY | +1676 bps QoQ) ■ PAT: 471 (Loss to Profit YoY | +110.0% QoQ) ■ EPS (INR): 0.29 (Loss to Profit YoY | +107.1% QoQ) Aksh Optifibre Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) Segmental Performance Manufacturing ■ Revenue: 3,018 (+76.2% YoY | +115.8% QoQ) ■ EBIT: 739 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 24.5 (Loss to Profit YoY | Loss to Profit QoQ) Services ■ Revenue: 1,969 (+101.5% YoY | -26.6% QoQ) ■ EBIT: 172 (Loss to Profit YoY | -36.9% QoQ) ■ EBIT Margin (%): 8.7 (Loss to Profit YoY | -142 bps QoQ)
Aksh Optifibre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Unaudited financial results ....
Intimation · 14 Aug 2026, 5:30 am
Aksh Optifibre Board Meeting Set for Aug'26 to Approve Q1 Results Aksh Optifibre Limited has scheduled a Board of Directors meeting for 14 Aug'26 to consider and approve its unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. The company is currently undergoing a Corporate Insolvency Resolution Process (CIRP) initiated on 19 Jun'26. The trading window for designated persons has been closed from 01 Jul'26 and will reopen 48 hours after the results are declared.
Order of Hon''ble NCLAT dated June 30, 2026
Others (Uncategorized) · 30 Jun 2026, 11:30 pm
Aksh Optifibre: NCLAT Stays Further CIRP Proceedings Pending Deposit Aksh Optifibre's promoter appealed to the NCLAT against a CIRP order. On 30th Jun'26, the NCLAT directed the Interim Resolution Professional (IRP) to halt further CIRP steps. This stay is conditional on the promoter depositing a total of Rs. 3.33 Cr (Rs. 2 Cr principal plus interest). The company will continue operations under IRP supervision with assistance from the promoter and staff. The NCLAT has allowed six weeks for the full payment to be deposited. The next hearing is scheduled for 06th Aug'26.
Receipt of Hon''ble NCLT Order
Others (Uncategorized) · 23 Jun 2026, 12:29 am
Public Announcement for CIRP and Invitation of Claims
Others (Uncategorized) · 21 Jun 2026, 2:55 am
Aksh Optifibre Initiates Corporate Insolvency Resolution Process (CIRP) Aksh Optifibre Limited has commenced its Corporate Insolvency Resolution Process (CIRP) as of 19th Jun'26, following an order by the National Company Law Tribunal. The company has invited creditors to submit claims by the deadline of 3rd Jul'26. The insolvency process is estimated to conclude by 16th Dec'26. This action stems from a petition filed by Shantanu Investments Pvt Ltd. Praveen Kumar Singhal has been appointed as the Interim Resolution Professional to oversee the proceedings.
Admission of Application u/s 7 of Insolvency and Bankruptcy Code of India (IBC)
Others (Uncategorized) · 20 Jun 2026, 5:32 pm
Aksh Optifibre Admitted into Corporate Insolvency Resolution Process The NCLT Jaipur Bench admitted an insolvency application against Aksh Optifibre on Jun 19, '26, under Section 7 of the IBC. The application, filed by Shantanu Investments Private Limited, concerns an outstanding amount of Rs. 2 crore plus interest. The court has ordered the commencement of the Corporate Insolvency Resolution Process (CIRP) for the company. An Interim Resolution Professional has been appointed, and a moratorium has been declared under Section 14 of the IBC. The detailed written order is awaited.
Intimation of Regulation 30 under SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 10 Jun 2026, 8:10 pm
Aksh Optifibre Appeals NCLT Ruling on Insolvency Application Aksh Optifibre has disclosed that an insolvency application filed against it by Shantanu Investments under Section 7 of the IBC has been deemed maintainable by the NCLT. This decision followed a referral to a third member due to a split verdict in the Jaipur Bench. Aksh Optifibre believes the order has factual and legal errors and has already filed an appeal with the National Company Law Appellate Tribunal (NCLAT). The company states it is pursuing all available legal remedies to challenge the ruling.
Appointment/Re-appointment of Auditors of the Company
Change in Management · 29 May 2026, 1:25 am
Aksh Optifibre FY26 Results: Narrows Losses, Auditor Issues Qualified Opinion Aksh Optifibre reported a consolidated net loss of ₹1,307.31 lakhs for FY26, narrowing from a loss of ₹2,596.66 lakhs in FY25. For Q4 FY26, the company posted a net profit of ₹224.26 lakhs, a significant turnaround from a loss of ₹665.13 lakhs YoY. Revenue from operations for FY26 was ₹12,723.11 lakhs. The auditor issued a qualified opinion, citing non-provisioning for liabilities of ₹2,986.54 lakhs. Recognizing this would increase the reported FY26 loss by ₹115.01 lakhs and decrease Q4 profit by ₹48.08 lakhs.
Audited Financial Results Standalone & Consolidated for the Quarter & Year March 31, 2026
Financial Result · 29 May 2026, 1:22 am
Aksh Optifibre Q4 Standalone Results Swing to Profit; Audit Report Qualified Aksh Optifibre reported a standalone profit after tax of ₹25.67 Lakh for Q4 ended 31 Mar'26, a significant turnaround from a loss of ₹1,760.53 Lakh YoY. Revenue from operations increased 26.4% YoY to ₹4,019.23 Lakh. For FY26, the company narrowed its net loss to ₹856.42 Lakh from ₹2,011.30 Lakh in FY25. The auditor issued a qualified opinion, noting non-provisioning of liabilities worth ₹2,986.54 Lakh related to government schemes. Had this been provisioned, FY26 loss would increase by ₹115.01 Lakh.
Outcome of Board Meeting for Consideration & Approval of Audited Financial Results (Standalone & Consolidated) for the Quarter & Year Ended March 31, 2026
Outcome · 29 May 2026, 1:04 am
Aksh Optifibre Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 4,083 (+23.8% YoY | +51.8% QoQ) ■ EBITDA: 160 (+1332.0% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 3.9 (+358 bps YoY | Loss to Profit QoQ) ■ PAT: 224 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 0.14 (Loss to Profit YoY | Loss to Profit QoQ) Aksh Optifibre Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) Segmental Performance Manufacturing ■ Revenue: 1,398 (-33.0% YoY | +0.1% QoQ) ■ EBIT: -304 (+27.7% YoY | +14.6% QoQ) ■ EBIT Margin (%): -21.7 (-160 bps YoY | +374 bps QoQ) Services ■ Revenue: 2,685 (+121.6% YoY | +107.7% QoQ) ■ EBIT: 272 (+201.6% YoY | +292.6% QoQ) ■ EBIT Margin (%): 10.1 (+269 bps YoY | +477 bps QoQ)
Aksh Optifibre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve the audited financial results ....
Intimation · 28 May 2026, 5:30 am
Aksh Optifibre Board Meeting on May 28 to Approve FY26 Results Aksh Optifibre Limited has scheduled a Board of Directors meeting on May 28, 2026. The agenda includes the consideration and approval of the audited standalone and consolidated financial results for the quarter and financial year ended Mar 31, 2026. The trading window for insiders, which was closed from Apr 01, 2026, will remain shut until 48 hours after the results are publicly disclosed. The board may also discuss other business matters during the meeting.
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Others (Uncategorized) · 21 Apr 2026, 8:51 pm
Aksh Optifibre Confirms Non-Applicability of Large Corporate Framework Aksh Optifibre Limited (NSE: AKSHOPTFBR) declared on 21 Apr'26 that it does not fall under the Large Corporate (LC) framework criteria as per SEBI regulations. This confirmation is for the period ending 31 Mar'26. Consequently, the company is not mandated to raise 25% of its incremental borrowings through debt securities. This filing indicates the company does not meet the specified thresholds for outstanding long-term borrowings or credit ratings required for LC classification.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 21 Apr 2026, 8:46 pm
Aksh Optifibre Confirms Non-Applicability of Large Corporate Framework Aksh Optifibre Limited confirmed on 21 Apr'26 that it does not qualify as a 'Large Corporate' under SEBI's framework for the period ending 31 Mar'26. The company reported its provisional and unaudited outstanding borrowing at ₹85.00 crore as of 31 Mar'26. Consequently, the requirements for a credit rating for FY26 and mandatory borrowing through debt securities are not applicable. The filing confirms the company is exempt from the related SEBI circular provisions.
Intimation of Regulation 30 under SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 27 Mar 2026, 11:38 pm
Aksh Optifibre Gets Favorable Ruling from Debt Recovery Tribunal Aksh Optifibre announced that the Debt Recovery Tribunal (DRT), Jaipur, has set aside the Demand and Possession Notices previously issued by Union Bank of India. In its order dated 24 Mar'26, the DRT quashed the securitisation actions initiated by the bank under the SARFAESI Act, 2002. This ruling follows the company's Securitisation Application, where it had earlier been granted an interim stay. The decision provides significant relief to the company regarding the bank's enforcement proceedings.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 25 Mar 2026, 11:06 pm
Aksh Optifibre Tax Demand Substantially Reduced Aksh Optifibre announced a Rectification Order from Rajasthan State Tax authorities dated 25 Mar'26 has significantly reduced a prior tax demand. The original demand of ₹5.73 crore plus interest and penalties, issued on 29 Dec'25, has been revised down to ₹94.22 lakh plus applicable interest and penalty. The company is appealing the remaining balance and foresees no material financial or operational impact at this stage. The demand was raised under the GST Acts.
Intimation under Regulation 30 of SEBI(LODR) Regulations, 2015
Others (Uncategorized) · 11 Feb 2026, 11:03 pm
Aksh Optifibre Receives AED 41.34 Million Demand Notice Aksh Optifibre has received a demand notice from Bank of Baroda, Dubai, for AED 41.34 million, received on 10th Feb'26. The notice relates to the encashment of a corporate guarantee provided by Aksh for a loan defaulted upon by its wholly-owned subsidiaries, AOL FZE and AOL Technologies FZE. The company states the maximum financial impact could be up to the demanded amount but is currently difficult to ascertain. Aksh Optifibre is reviewing the notice and evaluating its response, including potential legal remedies.